Mesothelin mediates cellular adhesion through binding to MUC16 [31,32], while in cancer it is involved in resistance to cell death, cell proliferation, invasive and metastatic potential, angiogenesis, apoptosis regulation and epithelial-to-mesenchymal transition [33,34,35,36,37]. This evidence concerns the gene MSLN and cancer.